• ADHAM, N., ROMANIEKO, P., HARTIG, P., WEINSHANK, R.L. & BRANCHEK, T.A. (1992). The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1Dα receptor. Mol. Pharmacol., 41, 17.
  • BERNATH, S. & ZIGMOND, M.J. (1988). Characterization of [3H]GABA release from striatal slices: evidence for a calcium independent process via the GABA uptake system. Neuroscience, 27, 563570.
  • BOULENGUEZ, P., RAWLINS, J.N.P., CHAUVEAU, J., JOSEPH, M.H., MITCHELL, S.N. & GRAY, J.A. (1997). Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway. Neuropharmacol., 35, 15211529.
  • BRUINVELS, A.T., LANDWEHRMEYER, B., GUSTAFSON, E.L., DURKIN, M.M, MENGOD, G., BRANCHEK, T.A., HOYER, D. & PALACIOS, J.M. (1994). Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacol., 33, 367386.
  • CASTRO, M.E., PASCUAL, J., ROMON, T., BERCIANO, J., FIGOLS, J. & PAZOS, A. (1998). 5-HT1B receptor binding in degenerative movement disorders. Brain Res., 790, 323328.
  • CHADHA, A., ATACK, J., SUR, C. & DUTY, S. (2000a). The 5-HT1B agonist, CP93129, inhibits GABA release from slices of rat globus pallidus and reverses akinesia following intrapallidal administration in the reserpine-treated rat. Br. J. Pharmacol., 129, 61P.
  • CHADHA, A., DAWSON, L.G., JENNER, P. & DUTY, S. (2000b). Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABAA receptor subunit gene expression in the rodent basal ganglia and thalamus. Neuroscience, 95, 119126.
  • COLPAERT, F.C. (1987). Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacol., 26, 14311440.
  • DAVIDSON, C. & STAMFORD, J.A. (1997). Serotonin efflux in the rat ventral lateral geniculate nucleus assessed by fast cyclic voltammetry is modulated by 5-HT1B and 5-HT1D autoreceptors. Neuropharmacol., 35, 16271634.
  • DAWSON, L.G., CHADHA, A., MEGALOU, M. & DUTY, S. (2000). The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat. Br. J. Pharmacol., 129, 541546.
  • GARDNER, C.R. & RICHARDS, M.H. (1981). Presence of radiolabelled metabolites in release studies using [3H]gamma-aminobutyric acid. J. Neurochem., 36, 15901593.
  • KIA, H.K., MIQUEL, M.C., BRISORGUEIL, M.J., RIAD, M., EL MESTIKAWY, S., HAMON, M. & VERGE, D. (1996). Immunocytochemical localization of serotonin-1A receptors in the rat central nervous system. J. Comp. Neurol., 365, 289305.
  • MACOR, J.E., BURKHART, C.A., HEYM, J.H., IVES, J.L., LEBEL, L.A., NEWMAN, M.E., NIELSEN, J.A., RYAN, K., SCHULZ, D.W. & TORGERSEN, L.K. (1990). 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole. J. Med. Chem., 33, 20872093.
  • MANEUF, Y., MITCHELL, I.J., CROSSMAN, A.R. & BROTCHIE, J.M. (1994). On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp. Neurol., 125, 6571.
  • PARENT, A. & HAZRATI, L.N. (1995). Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev., 20, 91127.
  • PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic co-ordinates, 2nd, edn. U.K.: Academic Press.
  • POMPEIANO, M., PALACIOS, J.M. & MENGOD, G. (1992). Distribution and cellular localization of mRNA coding for the 5-HT1A receptor in rat brain: correlation with receptor binding. J. Neurosci., 12, 440453.
  • PYCOCK, C., HORTON, R.W. & MARSDEN, C.D. (1976). The behavioural effects of manipulating GABA function in the globus pallidus. Brain Res., 116, 353359.
  • RIAD, M., GARCIA, S., WATKINS, K.C., JODOIN, N., DOUCET, E., LANGLOIS, X., EL MESTIKAWY, S., HAMON, M. & DESCARRIES, L. (2000). Somatodendritic localization of 5-HT1A and preterminal axomal localization of 5-HT1B serotonin receptors in adult rat brain. J. Comp. Neurol., 417, 181194.
  • ROBERTSON, R.G., GRAHAM, W.C., SAMBROOK, M.A. & CROSSMAN, A.R. (1991). Further investigations into the pathophysiology of MPTP-induced parkinsonian in the primate: an intracerebral microdialysis study of γ-aminobutyric acid in the lateral segment of the globus pallidus. Brain Res., 563, 278280.
  • SARI, Y., MIQUEL, M.-C., BRISORGUEIL, M.-J., RUIZ, G., DOUCET, E., HAMON, M. & VERGE, D. (1999). Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience, 88, 899915.
  • SEGOVIA, J., TOSSMAN, U., HERRERA-MARSCHITZ, M., GARCIA-MUNOZ, M. & UNGERSTEDT, U. (1986). γ-aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat. Neurosci. Lett., 70, 364368.
  • STANFORD, I.M. & LACEY, M.G. (1996). Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J. Neurosci., 16, 75667573.
  • STOCCHI, F., NORDERA, G. & MARSDEN, C.D. (1997). Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuation and dyskinesias. Clin. Neuropharmacol., 20, 95115.
  • WALDMEIER, P.C., WILLIAMS, M., BAUMANN, P.A., BISCHOFF, S., SILLS, M.A. & NEALE, R.F. (1988). Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5HT1 receptor subtypes in the rat brain. Naunyn Schmiedeberg's Arch. Pharmacol., 337, 609620.
  • WANAKA, A., KIYAMA, H., MURAKAMI, T., MATSUMOTO, M., KAMADA, T., MALBON, C.C. & TOHYAMA, M. (1989). Immunocytochemical localization of beta-adrenergic receptors in the rat brain. Brain Res., 485, 125140.